Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CervoMed (CRVO) Retained Earnings (2022 - 2025)

CervoMed's Retained Earnings history spans 9 years, with the latest figure at -$89.6 million for Q3 2025.

  • For Q3 2025, Retained Earnings fell 40.0% year-over-year to -$89.6 million; the TTM value through Sep 2025 reached -$89.6 million, down 40.0%, while the annual FY2024 figure was $56197.0, 100.1% up from the prior year.
  • Retained Earnings for Q3 2025 was -$89.6 million at CervoMed, down from -$783.0 in the prior quarter.
  • Across five years, Retained Earnings topped out at $56197.0 in Q4 2024 and bottomed at -$138.7 million in Q2 2022.
  • The 4-year median for Retained Earnings is -$52.8 million (2023), against an average of -$46.1 million.
  • The largest annual shift saw Retained Earnings plummeted 106233.83% in 2023 before it surged 100.1% in 2024.
  • A 4-year view of Retained Earnings shows it stood at -$52.3 million in 2022, then decreased by 4.16% to -$54.4 million in 2023, then surged by 100.1% to $56197.0 in 2024, then crashed by 159539.12% to -$89.6 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Retained Earnings are -$89.6 million (Q3 2025), -$783.0 (Q2 2025), and -$75.6 million (Q1 2025).